Clinical Trial Update: Efficacy and Tolerability of Xalatan in Patients

View source ↗

Summary

A completed clinical trial investigating efficacy and tolerability of Xalatan for glaucoma and ocular hypertension, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Xalatan (latanoprost)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Glaucoma, Ocular Hypertension | Status: COMPLETED | Results posted: 2009-08-03